Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-001506

VP Clinical Reg Affairs bought 250 shares at $16.50 ($4,125)

From the SEC's structured data for this filing

Trades in this filing

Thompson Jaye · VP Clinical Reg Affairs

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-01-13 Purchase : show line 1 in the form +250 $16.50 $4,125 256,745 D
Open-market purchases · 250 sh · avg $16.50 · $4,125
Loading xslF345X03/ownership.xml…